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Abstract
Few comprehensive studies have searched for viruses and bacteria in children with community-acquired pneumonia (CAP). We identi-
ﬁed 76 children hospitalized for pneumonia. Induced sputum samples were analysed for 18 viruses by antigen detection and PCR, and
for six bacteria by culture and PCR. Viruses were found in 72% of samples, bacteria in 91%, and both in 66%. Rhinovirus (30%), human
bocavirus (18%) and human metapneumovirus (14%) were the most commonly detected viruses. Two viruses were found in 22% of
samples and three in 8%. The most common bacteria found were Streptococcus pneumoniae (50%), Haemophilus inﬂuenzae (38%), and
Moraxella catarrhalis (28%). Rhinovirus–S. pneumoniae was the most commonly found combination of virus and bacterium (16%). All six
children with treatment failure had both viruses and bacteria detected in the sputum. Otherwise, we found no special clinical character-
istics in those with mixed viral–bacterial detections. With modern molecular diagnostic techniques, there are high rates of both viral
and bacterial identiﬁcation in childhood CAP. The clinical signiﬁcance of mixed viral–bacterial infections remains unclear, although we
found a potential association between them and treatment failure.
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Introduction
There are approximately 150 million cases of childhood com-
munity-acquired pneumonia (CAP) each year [1]. The aetiol-
ogy of pneumonia has been widely investigated (Table 1), but
so far no one has studied all of the most common childhood
CAP causative agents. According to previous studies, up to
two-thirds of childhood pneumonia cases are associated with
viral infection [2–6]. Respiratory syncytial virus (RSV), rhinovi-
rus (RV), human bocavirus (HBoV), human metapneumovirus
(HMPV) and parainﬂuenza viruses (PIVs) are the most com-
mon viruses associated with pneumonia [1–10]. With modern
molecular diagnostic techniques, an increasing number of
microorganisms can be detected, and recent aetiological
studies have reported increasing detection rates for mixed
viral–bacterial infections in children with CAP [2,3,5–7].
The aim of this study was to investigate thoroughly the
roles of all of the most common respiratory microorganisms
in the aetiology of CAP, and to determine the real preva-
lence of mixed viral–bacterial infections.
Materials and Methods
Sputum specimens were collected from children aged
6 months to 15 years with radiologically veriﬁed CAP trea-
ted in the Paediatric Infectious Disease Ward of Turku Uni-
versity Hospital (Turku, Finland) from January 2006 to April
2007. Pneumonia was deﬁned as the presence of pneumonic
inﬁltrates (alveolar or interstitial) on the chest radiograph
with simultaneous signs and/or symptoms of acute infection.
Sputum production was induced by inhalation of 5.0% hyper-
tonic saline solution, and the sputum sample was obtained by
aspirating through the nostrils (N = 69) or by expectoration
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if the child was old enough to produce an adequate sputum
sample (N = 7). A good-quality sputum sample with <25
squamous epithelial cells and >25 leukocytes per low-power
ﬁeld was obtained from 76 of 133 children otherwise eligible
for the study. The details of the sputum collection method
and preliminary microbiological results have been described
previously by Lahti et al. [9].
Viral antigen detection (inﬂuenza A and B viruses, PIV
types 1, 2 and 3, RSV, and adenovirus (AdV)) by time-
resolved ﬂuoroimmunoassay, and nucleic acid detection by
quantitative RT-PCR for enteroviruses, RV, RSV and HMPV,
and quantitative PCR for HBoV, were performed as
described previously [9]. We completed these viral studies
to maximize the number and variety of viruses recovered
from respiratory tract samples. Multiplex RT-PCR (Seeplex
RV12 ACE Detection; Seegene, Seoul, Korea) was used for
the detection of 12 respiratory pathogens (AdV, inﬂuenza A
and B viruses, RSV A and B, HMPV, PIV types 1, 2 and 3,
RV A and B, and coronaviruses 229E/NL63 and OC43/
HKU1) according to the manufacturer’s protocol. Sequence
analysis was used for RV species determination as described
elsewhere [11]. In addition, quantitative RT-PCRs detecting
human parechoviruses, PIV4, inﬂuenza C virus, and quantita-
tive PCR for AdV, were performed in separate assays. The
assay for human parechovirus has been described in detail
elsewhere [12]. The assays for PIV4, inﬂuenza C virus, and
AdV are described in the Supporting Information.
Gram staining, semiquantitative bacterial culture, quantita-
tive Streptococcus pneumoniae PCR on S. pneumoniae culture-
positive samples, Mycoplasma pneumoniae PCR and the IgM
immunoassay test for M. pneumoniae were previously per-
formed as described by Lahti et al. [9]. We completed these
bacterial studies by multiplex PCR (Prove-It Sepsis) searching
for respiratory bacteria (S. pneumoniae, Haemophilus inﬂuenzae,
Staphylococcus aureus and Streptococcus pyogenes), performed
by the manufacturer at Mobidiag (Helsinki, Finland) for 14 sam-
ples with negative results or only normal/mixed ﬂora found in
previous bacterial studies. All of the patients were previously
immunized against H. inﬂuenzae type b, and therefore only
non-typeable serogroups of H. inﬂuenzae were studied.
Univariate associations between age and the frequency
distribution of viral and bacterial pathogens were analysed
with logistic regression. Univariate associations between the
distributions of viral, bacterial and mixed viral–bacterial
detections and the clinical picture of illness were studied
with multinomial logistic regression analysis. The studied
predictor variables were the patient’s age, a white blood cell
count and a serum C-reactive protein level on admission,
TABLE 1. Viral aetiology of community-acquired pneumonia in children when one or more viruses were searched for by PCR
techniques
Juven
et al. [2]
Tsolia
et al. [3]
Cilla
et al. [4]
Hamano-
Hasegawa
et al. [7]
Nascimento-
Carvalho
et al. [5]
Samramsamruajkit
et al. [13]
Cevey-
Macherel
et al. [6]
Wolf
et al. [14]
O’Callaghan-
Gordo
et al. [8]
Country Finland Greece Spain Japan Brazil Thailand Switzerland Israel Mozambique
No. of cases 254 75 338 1700 184 257 99 1296 807
Hospitalized (%) 100 100 53 NG 100 100 100 77 100
Age (years) Mean 3.8 Median 7.2 Median <3 Range 0–19 Median 1.6 Median 1.3 Mean 2.4 Range 0–4 Range 0–5
Additional methods Cul, Ag,
Serol
None Cul, Ag None Ag, Serol None Cul, Ag, Serol Cul, Ag None
No. of viruses studied
(PCR)
12 (1) 9 (9) 14 (14) 12 (12) 9 (2) 8 (8) 13 (12) 8 (1) 11 (11)
Aetiology detected (%) 85 77 NG 77 78 NS 86 NS NS
Blood culture-positive
(%)
1 3 1 NG 5 NS 1 NS 11
Bacteria (total %) 53 40 NG 50 42 NS 53 NS NS
Viruses (total %) 62 65 67 43 60 49 67 47 49
‡2 viruses (%) (3
viruses, no.)
14 9 (1) 27 (9) 2 NG NG 12 5 20 (4)
Viruses and bacteria (%) 30 28 NG 15 23 NS 33 NS NS
Respiratory syncytial
virus (%)
29 3a 20 9 15 16 13 23 11
Rhinovirus (%) 24 45 14 15 21 NS 20 NS 41
Human bocavirus (%) NS NS 14 3 NS NS NS NS NS
Human metapneumovirus
(%)
NS 1 12 7 NS 9 13 8 8
Parainﬂuenza virus
types 1 2 and 3 (%)
10 8 11b 7 17 5 13 3 7b
Inﬂuenza A or B virus (%) 4 7 7 <2c 9 13 14 3 8
Adenovirus (%) 7 12 3 2 3 7 7 3 21
Coronaviruses (%) 3 NS 7 <2c NS NS 7 NS NS
Enteroviruses (%) NS NS NS <2c 5 NS 13 NS 4
Ag, antigen detection; Cul, viral culture; NG, not given; NS, not studied; Serol, viral enzyme immunoassay from paired serum samples.
aStudied children aged 5–14 years.
bPCR included types 1, 2, 3 and 4.
cInﬂuenza A and B viruses, coronavirus OC43, enterovirus.
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and the highest fever during stay at hospital. Thereafter, a
multiple multinomial logistic regression analysis was per-
formed with all of the predictor variables simultaneously.
Associations between viral, bacterial and mixed viral–bacte-
rial detections and the chest radiograph were studied with
Fisher’s exact tests. For children with at least one virus, the
univariate association between predictor variables and num-
ber of viruses was studied with logistic regression analysis.
Thereafter, a multiple logistic regression analysis was per-
formed with all of the predictor variables simultaneously.
The clinical pictures of the most commonly found combina-
tions of viruses and bacteria (the three most common
viruses (RV, HBoV and HMPV) with one or more bacteria,
and the three most common bacteria (S. pneumoniae, H. inﬂu-
enzae and Moraxella catarrhalis) with one or more viruses)
were compared by using one-way analysis of variance for
continuous variables and Fisher’s exact tests for chest radio-
graphs. The statistical analyses were performed with SAS
(version 9.2; SAS Institute, Cary, NC,USA). p-Values <0.05
were considered to be statistically signiﬁcant.
The study was approved by the Ethics Committee of the
Hospital District of South-West Finland. Signed, informed
consent was obtained from parents or guardians before en-
rolment.
Results
The mean age of the 76 patients was 4.7 years (standard
deviation, ±3.9 years). Respiratory microorganisms were
detected in 74 (97%) of our patients. Viruses were found in
55 (72%) and bacteria in 69 (91%) of the studied children.
Proportions of microbiological ﬁndings are shown in Fig. 1.
One child had six microorganisms (three bacteria and three
viruses) simultaneously detected (Fig. 2) and, altogether,
seven children had two or three bacteria with two or three
viruses co-detected (Table 2).
RV, HBoV, HMPV, AdV, PIV3, coronaviruses and RSV
were the most commonly detected viruses (Fig. 1). Two
viruses were detected in 17 (22%) of our patients and three
viruses in six (8%). HBoV–RV was the most common combi-
nation of multiple viruses detected (six cases). Of HBoV-
positive samples, 79% were also positive for other viruses.
RSV and HMPV were most commonly found as sole viral
agents (60% and 64%, respectively), whereas other viruses
were found as sole viral agents in £44% of cases. Sequence
analysis of 14 RV-positive samples revealed nine belonging to
RV A species and ﬁve to RV C species. Of children <5 years
of age, 80% had viruses detected. Of HBoV detections, 93%
were in children <5 years of age. Eight of 11 HMPV detec-
tions were in children aged 2–5 years. The mean age of chil-
dren with multiple viral ﬁndings was 2.6 years (standard
deviation, ±1.6 years).
Evidence of S. pneumoniae was found in 50% of our
patients. Several cases of H. inﬂuenzae, M. catarrhalis and
S. aureus infection were also detected (Fig. 1). Thirty-six chil-
dren were tested for serum IgM antibodies to M. pneumo-
niae, and seven (19%) of them had a positive result (these
ﬁndings are excluded from our statistics, because this test
was performed in only 47% of our study population). By
FIG. 1. Proportions of microbiological ﬁndings
in induced sputum in children with commu-
nity-acquired pneumonia. Proportions of viral,
bacterial and mixed viral–bacterial detections
are shown in the inside ﬁgure. Proportions of
the most commonly found viruses (right side)
and bacteria (left side) are shown in the out-
side ﬁgure, and the total percentage is over
100 because of co-detections of multiple
microorganisms. Total: 76 patients. *Myco-
plasma pneumoniae was found in 20% of those
36 patients who were studied both serologi-
cally and by PCR.
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multiplex PCR, the presence of bacteria was shown in ten
(71%) of 14 patients with initially negative culture results.
S. pneumoniae and M. catarrhalis were the most commonly
co-detected bacteria (12 cases), and the most commonly
found combination of viruses and bacteria was RV–S. pneu-
moniae (12 cases). Of the 38 patients with S. pneumoniae in
their sputum, 25 (66%) had a concomitant viral detection
(Table 2). In 34 (45%) of the studied children, sputum sam-
ples were collected after the onset of intravenous antibiotic
treatment.
No signiﬁcant difference in the clinical picture of pneumo-
nia was found, whether it was associated with viruses, bacte-
ria or both (Table 3). Children with interstitial inﬁltration
(14%) on the chest radiograph had evidence of a sole viral
or mixed viral–bacterial infection, but not of a sole bacterial
infection. Our data did not show any clinical correlation
between the clinical picture of pneumonia (the white blood
cell count and the serum C-reactive protein level on admis-
sion, the highest fever during stay at hospital, and duration
of fever ‡38C) and whether one or multiple viruses caused
it. Mixed viral–bacterial detections including S. pneumoniae
with one or more viruses were associated with higher white
blood cell counts on admission than H. inﬂuenzae with one
or more viruses (p 0.001) (Table 3). Other signiﬁcant clinical
distinctions between different concomitantly detected micro-
organisms were not found. All of the six children (8%) with
treatment failure (fever ‡38C lasting for ‡48 h regardless of
antibiotic treatment) had evidence of both viruses and bacte-
ria. Of the 19 children with a sole bacterial detection, 100%
had alveolar inﬁltration on the chest radiograph, 89% had a
serum C-reactive protein level ‡60 mg/L and 68% had a
white blood cell count ‡15.0 · 109/L on admission. Of chil-
dren with evidence of both viruses and bacteria, only 18%
had interstitial inﬁltration on the chest radiograph, 64% had
a serum C-reactive protein level ‡60 mg/L and 50% had a
white blood cell count ‡15.0 · 109/L on admission.
Discussion
Our observations suggest that the majority of childhood
CAP cases are associated with both viruses and bacteria.
Respiratory microorganisms were detected in 97% of the
children studied, and 84% of the cases were found to be
associated with viral–viral, viral–bacterial or bacterial–bacte-
rial co-detections (Table 2). Rhinovirus–S. pneumoniae was
the most commonly detected combination of virus and bac-
terium.
We studied the viral aetiology of childhood CAP by
searching for 18 respiratory viruses in sputum specimens,
and detected viruses in 72% of the children; this is the high-
est detection rate of viral aetiology reported [2–6]. Previ-
ously, the most comprehensive virological study searched for
14 viruses in nasopharyngeal aspirates from 338 children
with pneumonia, and suggested a viral aetiology in 67% [4].
RV, HBoV and HMPV were the most commonly detected
viruses in our study. Altogether, these viruses were respon-
sible for up to 57% of all viral detections. RV, either alone
or in combination with other viruses or bacteria, was identi-
ﬁed in one-third of the studied children. In previous studies,
RV has been detected in 14–45% of children with pneumo-
nia, suggesting a signiﬁcant role for RV in childhood pneumo-
nia [2–8]. Our detection rates for HBoV and HMPV were
also in line with earlier studies. Recent studies have identiﬁed
HMPV in 1–13% of children with pneumonia [3,4,6–8,13,14].
The role of HBoV as a causative agent of pneumonia is more
difﬁcult to assess, because, after a primary infection, HBoV
may persist for a longer time than other respiratory viruses
[15]. In a prospective study by Fry et al. [16], HBoV was
detected in 12% of hospitalized children <5 years of age who
had pneumonia. Moreover, HBoV was recently identiﬁed
FIG. 2. A chest radiograph of a girl aged 3 years and 9 months with
community-acquired pneumonia. Six potential pathogens were
detected in the sputum sample: Streptococcus pneumoniae, Moraxella
catarrhalis, Haemophilus inﬂuenzae, enterovirus, human bocavirus, and
rhinovirus. Parenchymal consolidation is seen in the right lung just
below the hilus. The clinical picture on admission included fever of
39.8C, fatigue, poor appetite, rhinitis, cough, right-sided acute otitis
media, right-sided ﬁne crackles on auscultation, a C-reactive protein
level of 108 mg/L, and a white blood cell count of 35.9 · 109/L. The
patient was treated with intravenous penicillin G. After 1 day of
treatment, the girl was afebrile and was discharged from hospital
with a course of oral amoxycillin for 7 days.
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serologically in 12% of children with CAP in Italy [17]. Glob-
ally, RSV continues to be the major pneumonia causative
virus [18]. In our study, RSV was detected at lower rates
(7%) than reported by other investigators, (15–29%) [2,4–
8,13,14], but this can be explained by our study period being
between two RSV epidemics.
With sputum samples as diagnostic specimens, bacteria
were demonstrated in 69 of our 76 study children. PCR
broadened the detection rate of bacteria substantially. Almost
half of our study population had intravenous antibiotic treat-
ment started before the collection of sputum samples, which
probably explains why some had negative results in the bacte-
rial culture with concurrent positive results in bacterial PCR.
Of bacterial detections, 41% included more than one bacte-
rium and 72% included a concomitant viral detection (Table 2),
which complicates investigation of the role of each microor-
ganism in the pathogenesis and clinical features of illness.
Two-thirds of our patients had viral–bacterial co-detections,
as compared with rates between 15% and 45% reported in
previous aetiological studies of childhood CAP [2,3,5–7,9,10].
A popular view is that primary viral infection is followed by
secondary bacterial infection. Consequently, it is difﬁcult to
estimate the true incidence of mixed viral–bacterial infections,
because the earlier infection may easily be undetected.
One interesting ﬁnding in our study was that two viruses
were found in 22% of the cases and three viruses in 8%. Mul-
tiple viral ﬁndings were commonly made among young chil-
dren, the mean age being 2.6 years. Cilla et al. [4] have
reported two viruses in 15% of studied children with pneu-
monia and three viruses in 3%. In our study, HBoV and RV
were the most common concomitantly detected viruses. Of
those with HBoV in the sputum, 79% also had other viruses
detected. This high rate of HBoV co-infection is in concor-
dance with many previous studies [16,19,20].
The clinical consequences of mixed infections are not fully
understood. Some evidence suggests that mixed viral–bacterial
infections may potentially induce more severe disease than
individual viral or bacterial infections [21–23]. Previously,
mixed inﬂuenza virus–S. aureus infection has been shown to be
able to cause severe, fatal pneumonia in children [22–25], and
mixed RV–S. pneumoniae infection has been shown to be asso-
ciated with severe pneumonia in adults [26]. In children with
invasive pneumococcal disease, viral co-infections are also
common and are possibly associated with higher mortality
[27]. Limited evidence suggests that viral co-infections may
also induce more severe clinical illness than individual viral
infections. Cilla et al. [4] have reported children with viral co-
infections being hospitalized more frequently than those
infected with a single virus. In addition, Esposito et al. [19]
demonstrated that HBoV co-infections with other viruses
were associated with greater disease burden (more hospital-
izations and loss of school days) in children with respiratory
tract infection than in those with HBoV infection alone. In our
study, it is of interest that all children (8%) with treatment fail-
ure had evidence of mixed viral–bacterial infection.
Our study has many important limitations. The diversity
of ﬁndings in relation to the size of our study population lim-
its the conclusions that can be drawn. The duration of the
study period was short. Only the sputum samples with a high
leukocyte count were included in this study. This may have
inﬂuenced our results, especially in terms of viruses which
may not induce leukocytes to the sputum. We did not use
TABLE 3. Clinical ﬁndings of children with community-acquired pneumonia associated with viruses, bacteria, both viruses and
bacteria, or the most common combinations of viruses and bacteria
Characteristic Viruses Bacteria
Both viruses
and bacteria
RV with ‡1
bacterium
HMPV with ‡1
bacterium
Streptococcus
pneumoniae
with ‡1 virus
Haemophilus
inﬂuenzae with ‡1
virus
N (%) 4 (5) 19 (25) 50 (66) 10 (13) 7 (9) 14 (18) 14 (18)
Age (years)a 2.0 (1.6–2.4) 6.0 (2.9–7.7) 4.4 (1.5–5.8) 5.4 (1.5–5.8) 4.1 (3.0–6.0) 6.4 (2.0–11.4) 3.5 (1.7–4.5)
On admission
White blood cell count
(109/L)a
18.6 (14.7–22.6) 20.1 (14.0–26.7) 17.0 (9.3–24.6) 21.0 (11.0–28.9) 11.3 (5.4–11.6) 21.4c (18.4–27.3) 11.3c (7.7–10.3)
Serum C-reactive
protein level (mg/L)a
82.5 (6.0–159.0) 166.4 (120.0–244.0) 121.8b1 (32.0–189.0) 129.9 (20.0–212.0) 50.3 (24.0–218.0) 132.6 (58.0–212.0) 99.3 (32.0–136.0)
Fever (C)a 40.1b2 (39.8–40.4) 39.7b1 (39.5–40.0) 39.7b7 (39.6–39.8) 39.6b1 (39.8–39.8) 39.6 (39.3–39.8) 39.9b1 (39.8–40.1) 39.7b2 (39.7–39.8)
Chest radiograph ﬁndings
Alveolar inﬁltrates,
n (%)
3 (75) 19 (100) 43 (86) 9 (90) 7 (100) 12 (86) 12 (86)
Interstitial inﬁltrates,
n (%)
1 (25) 0 (0) 9 (18) 1 (10) 1 (14) 2 (14) 3 (21)
HMPV, human metapneumovirus; RV, rhinovirus.
aValues are mean (interquartile range).
bNumber of missing data.
cSigniﬁcant difference (p 0.001) between the groups of S. pneumoniae with viruses and H. inﬂuenzae with viruses. Otherwise, there were no signiﬁcant differences (p £0.05)
in the clinical picture of community-acquired pneumonia between different aetiological groups.
Values of C-reactive protein level and fever were not available from all of the children and therefore the number of missing data is shown as superscripts in the table.
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serology, which could have established infections caused by
some viruses. It must be stressed that the detection of bac-
teria or viruses in the sputum sample does not necessarily
mean that they are the causative agents of the concomitant
lung infection. Bacteria might be contaminants from the
nasopharynx, which, in healthy young children, often carries
pathogenic bacteria. The detected virus might be found
because of the concomitant upper respiratory tract infection.
Furthermore, respiratory viruses, especially RV, have been
detected in asymptomatic children (up to 60% in children
<1 year of age) [28,29], but prolonged shedding of RV is not
known. Some respiratory viruses, such as HBoV and entero-
viruses, may show prolonged shedding for months after
acute infection [16]. Some bacteria, such as M. catarrhalis,
are known to be less virulent and less likely to cause pneu-
monia [30]. Some respiratory DNA viruses, such as AdV,
may be latent, and may be found by PCR but not be associ-
ated with the symptomatic infection. Thus, it is clear that the
term ‘causative agent’ should be used with caution.
In conclusion, our study suggests that viruses and bacteria
are commonly detected in children with CAP. Consequently,
our ﬁndings support the current guidelines that all children
with pneumonia should be treated with antibiotics, as the
detection of a virus does not allow a concomitant bacterial
infection to be ruled out. On the other hand, viral–bacterial
co-infection may manifest as an apparent treatment failure.
Viral pneumonia should receive greater attention in future
treatment and prevention studies.
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